Lynwood Capital Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Lynwood Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-518	Closed	-$268K	–	146
2022 Q4	$268K	Hold	518	–	–	0.32%	71
2022 Q3	$263K	Hold	518	–	–	0.29%	78
2022 Q2	$259K	Hold	518	–	–	0.29%	71
2022 Q1	$259K	Buy	+518	New	+$258K	0.28%	72

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lynwood Capital Management's TVGN Position: Q1 2023 in Review

Lynwood Capital Management sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 518 shares — an estimated $268K sold.

Lynwood Capital Management first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $268K in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Lynwood Capital Management reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Lynwood Capital Management sold 518 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $268K.
Lynwood Capital Management first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Lynwood Capital Management's Tevogen Inc. Common Stock position peaked at $268K in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Lynwood Capital Management's 13F filing for Q1 2023, filed 12 May 2023.